Îą-Fetoprotein, Îą-Fetoprotein-L3, and Des-Îł-Carboxy Prothrombin Stratify Hepatocellular Carcinoma Treatment Response and Progression Risk.

Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial.

Age period cohort analysis of rheumatic heart disease in high-income countries.

Biphasic pleural mesothelioma treated successfully with multimodal therapy: a case report.

Wearable Cardiac Rhythm Monitoring Device for Detection of Postoperative Atrial Fibrillation.

Robotic mitral repair after Rastelli operation and replacement of the aortic valve and right ventricle-pulmonary artery conduit.

Mortality trends of aortic stenosis in high-income countries from 2000 to 2020.

Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study.

The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease.

Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial.

Dynamic Analysis of Aerosol Release from a Pressurized Metered Dose Inhaler Combined with a Valved Holding Chamber Using Simplified Laser Photometry.

Mitral repair with leaflet preservation versus leaflet resection and ventricular reverse remodeling from a randomized trial.

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin.

Baseline neutrophil-to-lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling.

Impact of diabetes duration on left ventricular mass regression with empagliflozin.